Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6187465 | International Journal of Gynecology & Obstetrics | 2016 | 4 Pages |
Abstract
Before commencing chemotherapy or radiotherapy, patients in the oncology group at the margins of reproductive age had a diminished ovarian reserve compared with the control group. This should be considered when planning optimal doses of follicular stimulating hormone as part of controlled ovarian-stimulation regimes performed for embryo or oocyte cryopreservation prior to chemotherapy or radiotherapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Mashhour Naasan, Conor Harrity, Hassan Rajab, Noemi Ranisavljevic, Srwa Khalid, Edgar Mocanu,